HOME >> BIOLOGY >> NEWS
Blindness Linked To The Cytoskeleton?

A research group at the Max Planck Institute for Molecular Genetics in Berlin identified the gene defect underlying a specific form of hereditary blindness, known as retinitis pigmentosa (nature genetics, Vol. 19, No. 4, August 1998).

Retinitis pigmentosa (RD) is characterized by premature cell death in the retina leading to a progressive contraction of the visual field in affected patients. The retina lines the back of the eye and contains different types of cells, including the photoreceptors and neurons. There are two main classes of photoreceptor cells: rods and cones. Rods are responsible for vision under dim light conditions while cones participate in fine and color vision. RP leads to a preferential loss of the rod photoreceptor cells and night blindness is one of the first clinical symptoms. During disease progression, cones are affected as well and patients become legally blind between the ages of 20 and 40.

The name ‘retinitis pigmentosa’ reflects observations with patients in whom ophthalmologists frequently recognize an abnormal pigmentation in the back of the eye as a consequence of the dying photoreceptor cells. So far, 14 genes were identified which, when defective, lead to the disease. Additional 14 loci were defined by genetic linkage analysis in families affected by the disease. In these cases, the genetic defect still has to be identified. Most of the genes involved in retinitis pigmentosa encode proteins from the so called ‘phototransduction cascade’, a complex biochemical mechanism which transforms the initial light stimulus to a chemical signal. The latter accomplishes the communication of the photoreceptor cells with the neurons of the retina.

Retinitis pigmentosa, due to a genetic defect, occurs with a frequency of 1 in 4,000 individuals and about 15-25%
'"/>

Contact: Wolfgang Berger
berger@mpimg-berlin-dahlem.mpg.de
49-30-8413-1253
Max-Planck-Gesellschaft
4-Aug-1998


Page: 1 2 3 4

Related biology news :

1. Research to Prevent Blindness awards $4.8 million
2. Ribozymes To The Rescue: New UF Gene Therapy Shows Promise For Treatment Of Inherited Blindness
3. Genetic Clue Found To The Leading Cause Of Blindness In The United States
4. Scientists Identify Key Protein Involved In Progressive Blindness
5. UNMC, Boys Town National Research Hospital Researchers Locate Gene That Causes Combined Deafness And Blindness
6. New Retinal Surgery May Reverse Legal Blindness
7. Dog Blindness Gene May Help Humans
8. Alzheimers Disease And Developmental Biology Linked Through Single Molecule
9. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy
10. Seattle Researchers Zero In On Location Of Gene For Inherited Prostate Cancer; Gene Also Linked To Brain Cancer
11. Genetic Mutations Linked To Rare Metabolic Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based in ... into license agreements with Housey Pharma’s HMI subsidiary to gain access to its ... annual Research and Development spending in excess of US $10 billion. , Scientists ...
(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. is ... medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. ... chain for more than 10 years. Early in the COVID-19 crisis, we identified ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. While ... global economic downturn will only increase price pressures overall for the industry. The era ... from every product launch is critical. However, history shows that only a third of ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... Medial ... early detection and prevention of high-burden diseases, and Centric Consulting, a business and ... organizations to utilize existing data in order to identify and prioritize patients for ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, ... of laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining ... research team led by Dr MA has been using the zebrafish model to ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now ... up to 200 million stem cells. Depending on the patient's condition, treatment may be ... US will die having some form of Alzheimers dementia, and the incidence continues to ...
Breaking Biology Technology:
Cached News: